<DOC>
	<DOCNO>NCT00594009</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness mechanical device remove carbon dioxide blood patient chronic obstructive pulmonary disease ( COPD ) hospitalize intensive care unit exacerbation condition .</brief_summary>
	<brief_title>Venovenous CO2 Removal Patients With COPD Acute Respiratory Failure</brief_title>
	<detailed_description>This pilot study examine efficacy safety extracorporeal circuit remove carbon dioxide blood patient acute exacerbation COPD result acute acute chronic respiratory failure . The extracorporeal circuit consist venovenous configuration percutaneously insert 18 F double lumen catheter place central vein . Centrifugal pump heparin bond circuit use patient heparinized maintain ACT &gt; 180 . Circuit blood flow gas sweep speed adjust maximize CO2 removal minimize ventilator settings patient 's work breathing . Patients remain extracorporeal circuit maximum four day tolerate . Plasma Hemoglobin monitor daily .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>1 . Acute respiratory failure invasive mechanical ventilation 2 . Acute respiratory failure advance directive foregoing invasive mechanical ventilation 3 . Established diagnosis COPD 4 . Age group : 18 year great 1 . Significant vasopressor support 2 . Systolic BP &lt; 100 torr systolic despite vasopressor support 3 . Class III Class IV congestive heart failure 4 . Left ventricular ejection fraction &lt; 30 % previous echocardiogram 5 . Recent ( 6 month ) history myocardial infarction 6 . Coronary artery disease unstable angina 7 . Recent ( 6 month ) history venous embolism 8 . Uncontrolled coagulopathy ( INR &gt; 5 aPTT &gt; 80 ) despite corrective therapy 9 . History heparininduced thrombocytopenia adverse event follow administration heparin ( heparin group ) 10 . Pregnancy 11 . Severe chronic liver disease 12 . Severe anemia ( Hgb &lt; 9 gm/dl ) 13 . Any contraindication systemic anticoagulation heparin , include recent central nervous system injury hemorrhage , retinal hemorrhage recent hemorrhage sit control 14 . Technically unable access vessel ( obesity , limb deformity , previous surgery site , infection , etc . ) 15 . Evidence increase intracranial pressure history intracranial hemorrhage within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>